Combined tazemetostat and MAPKi enhances differentiation of papillary thyroid cancer cells harbouring BRAFV600E by synergistically decreasing global trimethylation of H3K27.
J Cell Mol Med
; 24(6): 3336-3345, 2020 03.
Article
in En
| MEDLINE
| ID: mdl-31970877
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyridones
/
Benzamides
/
Biphenyl Compounds
/
Histones
/
Cell Differentiation
/
Morpholines
/
Proto-Oncogene Proteins B-raf
/
Protein Kinase Inhibitors
/
Thyroid Cancer, Papillary
Limits:
Humans
Language:
En
Journal:
J Cell Mol Med
Journal subject:
BIOLOGIA MOLECULAR
Year:
2020
Type:
Article
Affiliation country:
China